MAZZI, BARBARA
 Distribuzione geografica
Continente #
NA - Nord America 573
EU - Europa 326
AS - Asia 126
AF - Africa 25
SA - Sud America 2
OC - Oceania 1
Totale 1.053
Nazione #
US - Stati Uniti d'America 559
SE - Svezia 142
IT - Italia 61
CN - Cina 51
BG - Bulgaria 41
SG - Singapore 35
DE - Germania 26
GB - Regno Unito 20
CA - Canada 13
AT - Austria 12
CI - Costa d'Avorio 12
SN - Senegal 12
TR - Turchia 12
FR - Francia 11
VN - Vietnam 10
IN - India 8
UA - Ucraina 6
HK - Hong Kong 5
RU - Federazione Russa 3
SA - Arabia Saudita 3
BE - Belgio 2
AU - Australia 1
BD - Bangladesh 1
BR - Brasile 1
CL - Cile 1
HR - Croazia 1
JP - Giappone 1
NG - Nigeria 1
PA - Panama 1
PL - Polonia 1
Totale 1.053
Città #
Fairfield 73
Woodbridge 64
Seattle 55
Chandler 53
Sofia 41
Houston 37
Ashburn 36
Wilmington 29
Serra 24
Cambridge 22
New York 22
Singapore 17
London 15
Santa Clara 14
Ottawa 13
Princeton 13
Abidjan 12
Ann Arbor 12
Boardman 12
Dakar 12
Lawrence 12
Vienna 12
Bremen 11
Beijing 10
Medford 10
Marseille 9
Ogden 9
Dearborn 8
Florence 8
Frankfurt am Main 8
Des Moines 7
Pisa 7
Istanbul 6
Nanjing 5
Aosta 4
Hong Kong 4
San Diego 4
Dong Ket 3
Fuzhou 3
Jeddah 3
Manchester 3
Munich 3
Shanghai 3
Brussels 2
Conshohocken 2
Da Nang 2
Hebei 2
Izmir 2
Milan 2
Nanchang 2
Quanzhou 2
Queens 2
Seacroft 2
Tianjin 2
Xiamen 2
Baotou 1
Chengdu 1
Chicago 1
Guangzhou 1
Harran 1
Hefei 1
Highland 1
Jiaxing 1
Kent 1
Kocaeli 1
Lagos 1
Malnate 1
Melbourne 1
Ningbo 1
Norwalk 1
Panama City 1
Pordenone 1
Pune 1
Rome 1
San Francisco 1
Santiago 1
Shenyang 1
Vicopisano 1
Warsaw 1
Xingtai 1
Zagreb 1
Totale 778
Nome #
Use of low-dose radioiodine ablation for Graves' orbitopathy: results of a pilot, perspective study in a small series of patients 141
Relationship between serum cholesterol and Graves’ orbitopathy (GO): a confirmatory study 118
VARIABLES AFFECTING THE LONG TERM OUTCOME OF GRAVES' ORBITOPATHY FOLLOWING HIGH DOSE INTRAVENOUS GLUCOCORTICOID PULSE THERAPY IN PATIENTS NOT TREATED WITH ORBITAL RADIOTHERAPY 114
Does Graves' Orbitopathy Ever Disappear? Answers to an Old Question 102
High Serum Cholesterol Is a Novel Risk Factor for Graves' Orbitopathy: Results of a Cross-Sectional Study 99
Serum antibodies against the insulin-like growth factor-1 receptor (IGF-1R) in Graves’ disease and Graves’ orbitopathy 90
Correlation between serum anti-TSH receptor autoantibodies (TRAbs) and the clinical feature of Graves’ orbitopathy 81
Intravenous glucocorticoid therapy for Graves' ophthalmopathy and acute liver damage: an epidemiological study 77
Retinal, choroidal and optic disc analysis in patients with Graves' disease with or without orbitopathy 69
Use of low-dose radioiodine ablation for Graves’ orbitopathy: results of a pilot, perspective study in a small series of patients 68
Rehabilitative orbital decompression for Graves’ orbitopathy: results of a randomized clinical trial 64
Choroidal vascularity index in thyroid-associated ophthalmopathy: a cross-sectional study 58
Totale 1.081
Categoria #
all - tutte 4.035
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.035


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020153 0 0 0 0 32 27 19 16 17 10 27 5
2020/202180 7 4 3 16 5 2 4 5 7 6 11 10
2021/2022197 0 3 0 19 50 17 2 6 28 27 4 41
2022/2023260 34 48 25 18 21 22 2 24 53 0 12 1
2023/2024115 2 9 10 1 14 25 5 8 2 2 20 17
2024/202565 3 12 5 30 15 0 0 0 0 0 0 0
Totale 1.081